Wysa’s AI Chat Therapy Earns FDA Breakthrough Status for Chronic Pain and Mental Health
Wysa's AI-driven CBT chatbot has received FDA Breakthrough Device Designation for chronic pain, depression, and anxiety after an independent trial found it outperformed standard orthopedic care and matched in-person counseling.